COMMUNIQUÉS West-GlobeNewswire

-
The IASLC 19th World Conference on Lung Cancer Arrives in Toronto, Canada
21/08/2018 -
NeoTherma Oncology Receives NCI Grant to Advance VectRx™ MRI Thermometry
21/08/2018 -
InCrowd Named as Finalist for Vendor of the Year from PM360
21/08/2018 -
Lixte Biotechnology Announces a Clinical Trial Agreement with Moffitt Cancer Center to Initiate Phase 1b/2 Trial Evaluating the Safety and Efficacy of LB-100 in Treatment of Patients with Low or Intermediate-1 Risk Myelodysplastic Syndrome
21/08/2018 -
Alpha II to Provide Claim Scrubbing and Medical Necessity Services to UAE-Based Manteq
21/08/2018 -
Innovation in school mental health literacy underway across Canada
21/08/2018 -
NewLink Genetics to Participate in the Baird Global Healthcare Conference
21/08/2018 -
Lexington Announces First Multicenter Clinical Study Site
21/08/2018 -
Company update: Global Kinetics Corporation hits significant clinical milestones on its trajectory to revolutionise the treatment of Parkinson’s disease
21/08/2018 -
Emerald Health Therapeutics Announces Appointment of Pure Sunfarms President and CEO
21/08/2018 -
First Patient Enrolled in Delcath Amended Registration Trial in Metastatic Ocular Melanoma
21/08/2018 -
Onconova Therapeutics Announces Plan for Expanding Rigosertib Clinical Trials for Patients with Myelodysplastic Syndromes (MDS) to South America with Pint Pharma
21/08/2018 -
Bionano Genomics Announces Pricing of Initial Public Offering
21/08/2018 -
CCAB Partners With ImmunoBiochem as it Launches New Co-Development Strategy to Advance Early-Stage Biotech Companies
21/08/2018 -
Princeton Facial Plastic Surgeon Introduces NovaThreads to Practice
21/08/2018 -
Progressive Care Inc. Reports 47% Increase in Prescriptions Filled During July 2018
21/08/2018 -
GBT Appoints Heidi L. Wagner as Senior Vice President, Government Affairs and Policy
21/08/2018 -
Rexahn Pharmaceuticals Announces Clinical Collaboration with Merck to Evaluate RX-5902 (Supinoxin™) in combination with KEYTRUDA® (pembrolizumab) for Triple Negative Breast Cancer
21/08/2018 -
BioDelivery Sciences to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
21/08/2018
Pages